Terms: = Bone cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Prognosis
181 results:
1. Natural history of bone-only metastasis in renal cell carcinoma.
Tang B; Duan R; Fan Z; Yan X; Li S; Zhou L; Li J; Xu H; Mao L; Lian B; Wang X; Bai X; Wei X; Li C; Cui C; Si L; Chi Z; Guo J; Sheng X
Urol Oncol; 2024 Apr; 42(4):119.e17-119.e22. PubMed ID: 38383241
[TBL] [Abstract] [Full Text] [Related]
2. Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Nabergoj M; Eikema DJ; Koster L; Platzbecker U; Sockel K; Finke J; Kröger N; Forcade E; Nagler A; Eder M; Tischer J; Broers AEC; Kuball J; Wilson KMO; Hunault-Berger M; Collin M; Russo D; Corral LL; Helbig G; Mussetti A; Scheid C; Gurnari C; Raj K; Drozd-Sokolowska J; Yakoub-Agha I; Robin M; McLornan DP
Bone Marrow Transplant; 2024 Mar; 59(3):395-402. PubMed ID: 38195984
[TBL] [Abstract] [Full Text] [Related]
3. The role of insulinoma-associated protein 1 in predicting the progression and prognosis of human olfactory neuroblastoma in China.
Yang Y; Yue C; Li Y; Piao Y
Pathol Res Pract; 2024 Jan; 253():155040. PubMed ID: 38171083
[TBL] [Abstract] [Full Text] [Related]
4. Progression before local control in osteosarcoma: Outcome and prognosis-predictive factors.
Halalsheh H; Amer S; Sultan I
Pediatr Blood Cancer; 2023 Nov; 70(11):e30649. PubMed ID: 37638816
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
Hochman MJ; Othus M; Hasserjian RP; Ambinder A; Brunner A; Percival MM; Hourigan CS; Swords R; DeZern AE; Estey EH; Karp JE
Leukemia; 2023 Sep; 37(9):1915-1918. PubMed ID: 37524919
[TBL] [Abstract] [Full Text] [Related]
6. A multi-institutional retrospective study of 340 cases of sinonasal malignant tumor.
Tsuji T; Asato R; Kada S; Kitamura M; Tamaki H; Mizuta M; Tanaka S; Watanabe Y; Hori R; Kojima T; Shinohara S; Takebayashi S; Maetani T; Harada H; Kitani Y; Kumabe Y; Tsujimura T; Honda K; Ichimaru K; Ushiro K; Omori K
Auris Nasus Larynx; 2024 Feb; 51(1):86-98. PubMed ID: 37248104
[TBL] [Abstract] [Full Text] [Related]
7. Oncological outcomes and prognostic factors of squamous cell carcinoma of the upper gingiva and hard palate: a retrospective study.
Cheval M; Lopez R; Delanoë F; Vergez S; Dupret-Bories A; Lusque A; Chabrillac E
Eur Arch Otorhinolaryngol; 2023 Oct; 280(10):4569-4576. PubMed ID: 37233750
[TBL] [Abstract] [Full Text] [Related]
8. The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
Passeri T; Gutman T; Hamza A; Adle-Biassette H; Girard E; Beaurepere R; Tariq Z; Mariani O; Dahmani A; Bourneix C; Abbritti R; Driouch K; Bohec M; Servant N; Baulande S; Decaudin D; Guichard JP; Calugaru V; Feuvret L; Guinebretière JM; Champion L; Bièche I; Froelich S; Mammar H; Masliah-Planchon J
J Neurosurg; 2023 Nov; 139(5):1270-1280. PubMed ID: 37029667
[TBL] [Abstract] [Full Text] [Related]
9. Predictors of Recurrence After Metastasis-directed Therapy in Oligorecurrent Prostate cancer Following Radical Prostatectomy.
Milenkovic U; Kuijk J; Roussel E; Devos G; Van den Broeck T; Van Eecke H; Vanderstichele A; Duvillier T; Verhamme L; Van Haute W; Goeman L; Berghen C; Joniau S; De Meerleer G
Eur Urol Oncol; 2023 Dec; 6(6):582-589. PubMed ID: 36878753
[TBL] [Abstract] [Full Text] [Related]
10. A retrospective analysis of the prognosis of Japanese patients with sarcoma brain metastasis.
Toda Y; Kobayashi E; Kubota D; Miyakita Y; Narita Y; Kawai A
Cancer Med; 2023 Apr; 12(8):9471-9481. PubMed ID: 36811144
[TBL] [Abstract] [Full Text] [Related]
11. High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia.
Yu X; Chen C; Hu Y; Li K; Zhang Y; Chen Z; Nie D; Gao R; Huang Y; Zhong M; Wang C; Wang S; Zeng Y; Li Y; Zeng C
Cancer Med; 2023 Apr; 12(7):9055-9067. PubMed ID: 36708053
[TBL] [Abstract] [Full Text] [Related]
12. Epidemiologic Survey of Myxofibrosarcoma Using Data from the bone and Soft Tissue Tumor Registry in Japan.
Kamio S; Matsumoto M; Nakamura M; Kawai A; Kikuta K
Ann Surg Oncol; 2023 May; 30(5):3074-3081. PubMed ID: 36437410
[TBL] [Abstract] [Full Text] [Related]
13. Spinal Lesions as Clinical Manifestations of Plasma Cell Neoplasia.
Baumgart L; Barz M; Delbridge C; Aftahy AK; Janssen IK; Jost PJ; Ryang YM; Meyer B; Gempt J
Curr Oncol; 2022 Aug; 29(9):6236-6244. PubMed ID: 36135059
[TBL] [Abstract] [Full Text] [Related]
14. Clinical Outcomes of Limb-sparing Tumor Surgery With Vascular Reconstruction for bone and Soft-tissue Tumors.
Asano Y; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Taniguchi Y; Morinaga S; Tada K; Nojima T; Tsuchiya H
Anticancer Res; 2022 Sep; 42(9):4619-4626. PubMed ID: 36039442
[TBL] [Abstract] [Full Text] [Related]
15. The clinical features, treatment, and prognostic factors for peripheral T-cell lymphomas: A single-institution analysis of 240 Chinese patients.
Chen H; Tao Y; Zhou Y; Liu P; Yang J; He X; Zhou S; Qin Y; Song Y; Gui L; Zhang C; Yang S; Shi Y
Asia Pac J Clin Oncol; 2023 Oct; 19(5):e202-e214. PubMed ID: 35821612
[TBL] [Abstract] [Full Text] [Related]
16. Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma.
Wang X; Espin-Garcia O; Jiang DM; Allen MJ; Ma LX; Bach Y; Chen EX; Darling G; Yeung JC; Wong RKS; Veit-Haibach P; Kalimuthu S; Jang RW; Elimova E
Oncology; 2022; 100(8):439-448. PubMed ID: 35764050
[TBL] [Abstract] [Full Text] [Related]
17. Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis.
Shimony S; Canaani J; Kugler E; Nachmias B; Ram R; Henig I; Frisch A; Ganzel C; Vainstein V; Moshe Y; Aumann S; Yeshurun M; Ofran Y; Raanani P; Wolach O
Ann Hematol; 2022 Sep; 101(9):2001-2010. PubMed ID: 35739428
[TBL] [Abstract] [Full Text] [Related]
18. Whole-genome sequencing as an alternative to analyze copy number abnormalities in acute myeloid leukemia and myelodysplastic syndrome.
Lyu X; Li T; Zhu D; Cheng Y; Chen Y; He X; Li Z; Li S; Wu W; Geng S; Zhang M; Yao C; Li J; Li Y; Chang Y; Li Y; Zhu Z; Mao M; Song Y
Leuk Lymphoma; 2022 Oct; 63(10):2301-2310. PubMed ID: 35695096
[TBL] [Abstract] [Full Text] [Related]
19. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM
Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071
[TBL] [Abstract] [Full Text] [Related]
20. AML with inv(16)/t(16;16) and high-risk cytogenetic abnormalities: atypical features and unfavorable outcome.
Assaf N; Lefebvre C; Raggueneau V; Guignedoux G; Marceau-Renaut A; Chevalier S; Tondeur S; Bories D; Benramdane R; Rousselot P; Terré C
Hematology; 2022 Dec; 27(1):636-641. PubMed ID: 35622005
[TBL] [Abstract] [Full Text] [Related]
[Next]
